Loading clinical trials...
Loading clinical trials...
B7 Coreceptor Molecules as Clinically-Relevant Surrogate Biomarkers in the Hyper IgD Syndrome (HIDS) Form of Mevalonate Kinase Deficiency (MKD)
Conditions
Locations
4
United States
Michigan Techinical University
Houghton, Michigan, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Oregon Health & Science University
Portland, Oregon, United States
Radbound University of Nijmegen Medical Centre
Nijmegen, Netherlands
Start Date
March 1, 2012
Primary Completion Date
March 1, 2016
Completion Date
March 1, 2016
Last Updated
June 18, 2018
Lead Sponsor
Michigan Technological University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions